|
|
Author : Lyubota I.I. The effectiveness of the use of metformin in breast cancer patients with metabolic syndromeAuthors: Lyubota R.V. Cheshuk V.Ye. Vereshchako R.I. Zotov O.S.... №2(22) 2016 Prognostic value of androgen receptor expression in breast cancer cellsAuthors: Lyubota R.V. Vereshchako R.I. Cheshuk V.Ye. Anikusko N.F.... №1(17) 2015 Evaluating the effectiveness of preoperative radiation therapy of primary-operable breast cancerAuthors: Schepotin I.B. Zotov A.S. Lyubota R.V. Lyubota I.I.... №7 (3) 2012 Clinical and biological features of triple negative breast cancerAuthors: Schepotin I.B. Zotov A.S. Lyubota R.V. Anikusko N.F.... №5 (1) 2012 Neoadjuvant hormonal therapy of locally advanced breast cancerAuthors: Schepotin I.B. Zotov A.S. Anikusko N.F. Lyubota I.I.... №3 (3) 2011 Role and site of surgical treatment on survival of patients with primary advanced breast cancerAuthors: Schepotin I.B. Cheshuk V.Ye. Anikusko N.F. Lyubota I.I.... №3 (3) 2011 Features of the follow invasive breast cancer in patients with metabolic syndromeAuthors: Schepotin I.B. Zotov A.S. Lyubota I.I. Lyubota R.V. №1 (1) 2011 |
|